Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF.

Eur Heart J Cardiovasc Pharmacother · 2025 · PMC12582660 · PMID 40839760

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

On the other hand, as expected, we did observe a significant trend in NT-proBNP levels across EQ-5D categories in DAPA-HF and DELIVER trials.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.